Search Results - "Bruno‐Ventre, Marta" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Clinical features, management and prognosis of multifocal primary bone lymphoma: a retrospective study of the international extranodal lymphoma study group (the IELSG 14 study)

Clinical features, management and prognosis of multifocal primary bone lymphoma: a retrospective study of the international extranodal lymphoma study group (the IELSG 14 study)

by Messina, Carlo, Ferreri, Andrés J. M., Govi, Silvia, Bruno‐Ventre, Marta, Gracia Medina, Elías A., Porter, David, Radford, John, Heo, Dae S., Park, Hee Y., Pro, Barbara, Jayamohan, Jayasingham, Visco, Carlo, Scarfò, Lydia, Zucca, Emanuele, Gospodarowicz, Mary, Christie, David
Published in British journal of haematology (01.03.2014)

Get full text

Journal Article

Risk‐tailored CNS prophylaxis in a mono‐institutional series of 200 patients with diffuse large B‐cell lymphoma treated in the rituximab era

Risk‐tailored CNS prophylaxis in a mono‐institutional series of 200 patients with diffuse large B‐cell lymphoma treated in the rituximab era

by Ferreri, Andrés J. M., Bruno‐Ventre, Marta, Donadoni, Giovanni, Ponzoni, Maurilio, Citterio, Giovanni, Foppoli, Marco, Vignati, Alessandro, Scarfò, Lydia, Sassone, Marianna, Govi, Silvia, Caligaris‐Cappio, Federico
Published in British journal of haematology (01.03.2015)

Get full text

Journal Article

Clinical Features, Management, and Prognosis of an International Series of 161 Patients With Limited‐Stage Diffuse Large B‐Cell Lymphoma of the Bone (the IELSG‐14 Study)

Clinical Features, Management, and Prognosis of an International Series of 161 Patients With Limited‐Stage Diffuse Large B‐Cell Lymphoma of the Bone (the IELSG‐14 Study)

by Bruno Ventre, Marta, Ferreri, Andrés J.M., Gospodarowicz, Mary, Govi, Silvia, Messina, Carlo, Porter, David, Radford, John, Heo, Dae Seog, Park, Yeon, Martinelli, Giovanni, Taylor, Emma, Lucraft, Helen, Hong, Angela, Scarfò, Lydia, Zucca, Emanuele, Christie, David
Published in The oncologist (Dayton, Ohio) (01.03.2014)

Get full text

Journal Article

Safety and activity of a new intensive short-term chemoimmunotherapy in HIV-positive patients with Burkitt lymphoma

Safety and activity of a new intensive short-term chemoimmunotherapy in HIV-positive patients with Burkitt lymphoma

by Ferreri, Andrés J. M., Bruno Ventre, Marta, Donadoni, Giovanni, Cattaneo, Chiara, Fumagalli, Luca, Foppoli, Marco, Mappa, Silvia, Govi, Silvia, Nicola, Massimo Di, Rossi, Giuseppe, Tirelli, Umberto, Caligaris-Cappio, Federico, Spina, Michele, Re, Alessandro
Published in British journal of haematology (01.10.2012)

Get full text

Journal Article

The clinical features, management and prognosis of primary and secondary indolent lymphoma of the bone: a retrospective study of the International Extranodal Lymphoma Study Group (IELSG #14 study)

The clinical features, management and prognosis of primary and secondary indolent lymphoma of the bone: a retrospective study of the International Extranodal Lymphoma Study Group (IELSG #14 study)

by Govi, Silvia, Christie, David, Mappa, Silvia, Marturano, Emerenziana, Bruno-Ventre, Marta, Messina, Carlo, Medina, Elías A. Gracia, Porter, David, Radford, John, Heo, Dae Seog, Park, Yeon, Pro, Barbara, Jayamohan, Jayasingham, Pavlakis, Nick, Zucca, Emanuele, Gospodarowicz, Mary, Ferreri, Andrés J. M.
Published in Leukemia & lymphoma (01.08.2014)

Get full text

Journal Article

Treatment of HIV-Associated Burkitt Lymphoma

Treatment of HIV-Associated Burkitt Lymphoma

by Donadoni, Giovanni, Bruno-Ventre, Marta, Ferreri, Andrés J. M.
Published in European medical journal. Hematology (01.08.2013)

Get full text

Journal Article

High Doses of Antimetabolites Followed by High-Dose Sequential Chemoimmunotherapy and Autologous Stem-Cell Transplantation in Patients With Systemic B-Cell Lymphoma and Secondary CNS Involvement: Final Results of a Multicenter Phase II Trial

High Doses of Antimetabolites Followed by High-Dose Sequential Chemoimmunotherapy and Autologous Stem-Cell Transplantation in Patients With Systemic B-Cell Lymphoma and Secondary CNS Involvement: Final Results of a Multicenter Phase II Trial

by Ferreri, Andrés J M, Donadoni, Giovanni, Cabras, Maria Giuseppina, Patti, Caterina, Mian, Michael, Zambello, Renato, Tarella, Corrado, Di Nicola, Massimo, D'Arco, Alfonso M, Doa, Gianluca, Bruno-Ventre, Marta, Assanelli, Andrea, Foppoli, Marco, Citterio, Giovanni, Fanni, Alessandro, Mulè, Antonino, Caligaris-Cappio, Federico, Ciceri, Fabio
Published in Journal of clinical oncology (20.11.2015)

Get full text

Journal Article

Selective intra-graft apoptosis and down-regulation of lymphocyte bcl-2, INOs and CD95L expression in kidney-pancreas transplanted patients after anti-Thymoglobulin induction

Selective intra-graft apoptosis and down-regulation of lymphocyte bcl-2, INOs and CD95L expression in kidney-pancreas transplanted patients after anti-Thymoglobulin induction

by FIORINA, Paolo, TORRIANI, Gabriele, GREMIZZI, Chiara, DAVALLI, Alberto M, ORSENIGO, Elena, BRUNO VENTRE, Marta, DELL ANTONIO, Giacomo, DI CARLO, Valerio, ROSSINI, Silvano, SECCHI, Antonio
Published in Transplant international (01.11.2004)

Get full text

Journal Article

Dosing Pattern of Ruxolitinib (RUX) in Patients with Myelofibrosis (MF) in Italy: Results from a Prospective Observational Study (ROMEI)

Dosing Pattern of Ruxolitinib (RUX) in Patients with Myelofibrosis (MF) in Italy: Results from a Prospective Observational Study (ROMEI)

by Breccia, Massimo, Guglielmelli, Paola, Mendicino, Francesco, Malato, Alessandra, Palumbo, Giuseppe A., Selleri, Carmine, Cilloni, Daniela, Mazza, Patrizio, Siragusa, Sergio, Abruzzese, Elisabetta, Martelli, Maurizio, Benevolo, Giulia, Rinaldi, Erminia, Crugnola, Monica, Rupoli, Serena, Pavone, Vincenzo, Bonifacio, Massimiliano, Pane, Fabrizio, Carli, Giuseppe, Langella, Maria, Bruno Ventre, Marta, Elli, Elena Maria, Impera, Stefana, Liberati, Anna Marina, Di Renzo, Nicola, Martino, Bruno, Sportoletti, Paolo, Tiribelli, Mario, Binotto, Gianni, Annunziata, Mario, Di Ianni, Mauro, La Nasa, Giorgio, Falcone, Antonietta Pia, Leanza, Rossana, Volpe, Antonio, Gherlinzoni, Filippo, De Stefano, Valerio, Vallisa, Daniele, Leonetti Crescenzi, Sabrina, Cavazzini, Francesco, Ricco, Alessandra, Barberio, Carmela, Misto, Alessandra, Passamonti, Francesco, Palandri, Francesca
Published in Blood (15.11.2022)

Get full text

Journal Article

Interim Analysis Of An Ongoing PHASE II Trial Assessing Safety and Efficacy Of Lenalidomide Maintenance In Patients With Chemosensitive Relapse Of Diffuse Large B-CELL Lymphoma (DLBCL)

Interim Analysis Of An Ongoing PHASE II Trial Assessing Safety and Efficacy Of Lenalidomide Maintenance In Patients With Chemosensitive Relapse Of Diffuse Large B-CELL Lymphoma (DLBCL)

by Govi, Silvia, Ventre, Marta Bruno, Zaja, Francesco, Di Rocco, Alice, Spina, Michele, Vallisa, Daniele, Scarfo', Lydia, Chiozzotto, Marianna, Cuccurullo, Rosanna, Fama, Angelo, Ferreri, Andrés J.M.
Published in Blood (15.11.2013)

Get full text

Journal Article

Risk-Tailored CNS Prophylaxis In 194 Patients With Diffuse Large B-CELL Lymphoma (DLBCL) Treated In The Rituximab ERA: Risk Definition By Clinical Variables and Ontogenic Stratification

Risk-Tailored CNS Prophylaxis In 194 Patients With Diffuse Large B-CELL Lymphoma (DLBCL) Treated In The Rituximab ERA: Risk Definition By Clinical Variables and Ontogenic Stratification

by Ventre, Marta Bruno, Foppoli, Marco, Citterio, Giovanni, Donadoni, Giovanni, Ponzoni, Maurilio, Govi, Silvia, Scarfò, Lydia, Sassone, Marianna, Caligaris -Cappio, Federico, Ferreri, Andres J.M.
Published in Blood (15.11.2013)

Get full text

Journal Article

High Doses of Antimetabolites Followed By High-Dose Sequential Chemoimmunotherapy and Autologous Stem Cell Transplant in Patients with Systemic B-Cell Lymphoma and Secondary Central Nervous System Involvement: Final Results of a Multicenter Phase II Trial

High Doses of Antimetabolites Followed By High-Dose Sequential Chemoimmunotherapy and Autologous Stem Cell Transplant in Patients with Systemic B-Cell Lymphoma and Secondary Central Nervous System Involvement: Final Results of a Multicenter Phase II Trial

by Ferreri, Andrés J.M., Donadoni, Giovanni, Cabras, Maria Giuseppina, Patti, Caterina, Mian, Michael, Zambello, Renato, Tarella, Corrado, Di Nicola, Massimo, D’Arco, Alfonso, Doa, Gianluca, Bruno-Ventre, Marta, Foppoli, Marco, Fanni, Alessandro, Mulè, Antonino, Ciceri, Fabio, Caligaris-Cappio, Federico
Published in Blood (06.12.2014)

Get full text

Journal Article

Feasibility and efficacy of high doses of antimetabolites followed by high-dose sequential chemoimmunotherapy (R-HDS) and autologous stem cell transplant (ASCT) in patients (pts) with systemic B-cell lymphoma (BCL) and central nervous system (CNS) involvement: A multicenter phase II trial

Feasibility and efficacy of high doses of antimetabolites followed by high-dose sequential chemoimmunotherapy (R-HDS) and autologous stem cell transplant (ASCT) in patients (pts) with systemic B-cell lymphoma (BCL) and central nervous system (CNS) involvement: A multicenter phase II trial

by Ferreri, Andres J.M., Donadoni, Giovanni, Cabras, Maria Giuseppina, Patti, Caterina, Mian, Michael, Zambello, Renato, Tarella, Corrado, Di Nicola, Massimo A., D'Arco, Alfonso, Bruno Ventre, Marta, Foppoli, Marco, Fanni, Alessandro, Doa, Gianluca, Mulè, Antonio, Caligaris-Cappio, Federico, Ciceri, Fabio
Published in Journal of clinical oncology (20.05.2014)

Get full text

Journal Article

Non Pegilated Liposomal Doxorubicin (TLC-D99; Myocet ™) Can Be Safely and Effectively Used As Part of the R-COMP Regimen in Patients with Diffuse Large B-Cell Lymphoma Who Show Contraindications to Anthracyclines Due to Concomitant Moderate/Severe Heart Disease. Results of the HEART01 Phase II trial by the Fondazione Italiana Linfomi (NCT01009970)

Non Pegilated Liposomal Doxorubicin (TLC-D99; Myocet ™) Can Be Safely and Effectively Used As Part of the R-COMP Regimen in Patients with Diffuse Large B-Cell Lymphoma Who Show Contraindications to Anthracyclines Due to Concomitant Moderate/Severe Heart Disease. Results of the HEART01 Phase II trial by the Fondazione Italiana Linfomi (NCT01009970)

by Spina, Michele, Luminari, Stefano, Ferreri, Andrés J.M., Zaja, Francesco, Balzarotti, Monica, Salvi, Flavia, Micheletti, Moira, Musuraca, Gerardo, Viel, Elda, Volpetti, Stefano, Pesce, Emanuela Anna, Ventre, Marta Bruno, Federico, Massimo
Published in Blood (16.11.2012)

Get full text

Journal Article

Safety and Activity of Intensive Short-Term Chemoimmunotherapy in HIV-Positive (HIV+) Patients (pts) with Burkitt Lymphoma (BL)

Safety and Activity of Intensive Short-Term Chemoimmunotherapy in HIV-Positive (HIV+) Patients (pts) with Burkitt Lymphoma (BL)

by Ventre, Marta Bruno, Donadoni, Giovanni, Re, Alessandro, Spina, Michele, Cattaneo, Chiara, Fumagalli, Luca, Mappa, Silvia, Govi, Silvia, Rossi, Giuseppe, Tirelli, Umberto, Ferreri, Andrés JM
Published in Blood (18.11.2011)

Get full text

Journal Article

Final Results of a Multicenter Phase II Trial with Translational Elements to Investigate the Possible Infective Causes of Ocular Adnexal Marginal Zone B-Cell Lymphoma (OAMZL) with Particular Reference to Chlamydia Species and the Efficacy of Doxycycline As First-Line Lymphoma Treatment (the IELSG#27 TRIAL)

Final Results of a Multicenter Phase II Trial with Translational Elements to Investigate the Possible Infective Causes of Ocular Adnexal Marginal Zone B-Cell Lymphoma (OAMZL) with Particular Reference to Chlamydia Species and the Efficacy of Doxycycline As First-Line Lymphoma Treatment (the IELSG#27 TRIAL)

by Govi, Silvia, Dolcetti, Riccardo, Ponzoni, Maurilio, Pasini, Elisa, Mappa, Silvia, Ventre, Marta Bruno, Doglioni, Claudio, Bertoni, Francesco, Zaja, Francesco, Montalban, Carlos, Stelitano, Caterina, Cabrera, Maria Elena, Cavalli, Franco, Zucca, Emanuele, Ferreri, Andrés J.M.
Published in Blood (18.11.2011)

Get full text

Journal Article

WT1 Transcripts Is a Powerful Leukemia Marker to Predict Early Relapse After Allogeneic Haematopoietic Stem Cell Transplantation

WT1 Transcripts Is a Powerful Leukemia Marker to Predict Early Relapse After Allogeneic Haematopoietic Stem Cell Transplantation

by Messina, Carlo, Tresoldi, Cristina, Stanghellini, Maria Teresa Lupo, Crotta, Alessandro, Girlanda, Stefania, Coppola, Milena, Piemontese, Simona, Greco, Raffaella, Malato, Simona, Forno, Barbara, Assanelli, Andrea, Clerici, Daniela, Mastaglio, Sara, Giglio, Fabio, Ventre, Marta Bruno, Lunghi, Francesca, Guggiari, Elena, Carrabba, Matteo Giovanni, Marcatti, Magda, Corti, Consuelo, Bonini, Chiara, Fleischhauer, Katharina, Peccatori, Jacopo, Bordignon, Claudio, Ciceri, Fabio, Bernardi, Massimo
Published in Blood (20.11.2009)

Get full text

Journal Article

Bendamustine Combined with Donor Lymphocytes Infusion in Hodgkin's Lymphoma Relapsing after Allogeneic Hematopoietic Stem Cell Transplantation

Bendamustine Combined with Donor Lymphocytes Infusion in Hodgkin's Lymphoma Relapsing after Allogeneic Hematopoietic Stem Cell Transplantation

by Sala, Elisa, Crocchiolo, Roberto, Gandolfi, Sara, Bruno-Ventre, Marta, Bramanti, Stefania, Peccatori, Jacopo, Sarina, Barbara, Corti, Consuelo, Ciceri, Fabio, Santoro, Armando, Marktel, Sarah, Castagna, Luca
Published in Biology of blood and marrow transplantation (01.09.2014)

Get full text

Journal Article

Selective intra‐graft apoptosis and down‐regulation of lymphocyte bcl‐2, iNOs and CD95L expression in kidney‐pancreas transplanted patients after anti‐Thymoglobulin induction

Selective intra‐graft apoptosis and down‐regulation of lymphocyte bcl‐2, iNOs and CD95L expression in kidney‐pancreas transplanted patients after anti‐Thymoglobulin induction

by Fiorina, Paolo, Torriani, Gabriele, Gremizzi, Chiara, Davalli, Alberto M., Orsenigo, Elena, Ventre, Marta Bruno, Dell'Antonio, Giacomo, Carlo, Valerio, Rossini, Silvano, Secchi, Antonio
Published in Transplant international (01.11.2004)

Get full text

Journal Article